Deals
NMC Founder Shetty Weighs Sale of Pharma Business
- Neopharma could be valued at as much as $1 billion in a deal
- Shetty planned to sell shares in the unit before NMC troubles
This article is for subscribers only.
NMC Health Plc founder Bavaguthu Raghuram Shetty is considering selling his Abu Dhabi-based pharmaceuticals business, Neopharma, after drawing interest from potential investors, according to people with knowledge of the matter.
Shetty, who resigned as chairman of the troubled hospital operator last month, has been approached by parties, including regional investors and family offices, the people said, asking not to be identified because the matter is private. Neopharma could be valued at between $700 million and $1 billion, they said.